Viewing nowCombinationEmpavex Tablets 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.

MFDS item code 202501700 · Approved 2025.07.08 · Insurance code 652904750
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to assist adult patients with type 2 diabetes in controlling blood sugar, alongside diet and exercise therapy. It is particularly suitable for individuals whose blood sugar is not adequately controlled, and special care is needed for patients with accompanying cardiovascular diseases. This drug is used as an adjunct to effectively improve blood glucose levels and assist in diabetes management.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is required in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use 2. Patients in Whom the Medicine Must Not Be Used, item 2)). Elderly patients Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.
This medication can cause a rare but serious side effect known as severe lactic acidosis, so caution is needed. Care should be taken if this drug is used in conjunction with insulin or sulfonylurea medications, as there is a risk of hypoglycemia. This drug should not be used in patients with significantly impaired renal function or acute conditions that may affect renal function. Patients in acute or chronic metabolic acidosis, those with type 1 diabetes, or those suffering from acute myocardial infarction, shock, etc. should also avoid this medication. Administration should be suspended when undergoing tests involving iodine-based contrasts, and it can be resumed once kidney function has returned to normal. Patients scheduled for surgery should stop taking this medication 48 hours prior to surgery and can resume once normal kidney function has been confirmed post-surgery. It is safest for pregnant women, those who may become pregnant, and nursing mothers not to use this medication. As this drug is affected by kidney function, regular checks of renal function should be conducted before and during administration, and if renal function worsens, discontinuation of the medication is necessary. Patients at risk of fluid loss or dehydration should be monitored closely for fluid status while using this drug. This medication may increase the risk of urinary or genital infections, so any infection symptoms should be reported to a healthcare professional immediately. Long-term use may decrease vitamin B12 levels, so it is advisable to periodically check vitamin B12 levels. Alcohol consumption may increase the risk of lactic acidosis, so excessive drinking should be avoided while taking this medication. This drug can induce hypoglycemia, so care should be taken in cases of missed meals or after vigorous exercise, and immediate action should be taken if hypoglycemic symptoms occur. Elderly patients are at higher risk of diminished kidney function, so dosage adjustments and regular monitoring of kidney function are necessary. Overdose may result in severe side effects such as lactic acidosis, necessitating immediate medical attention. This drug has not been established for safety and effectiveness in children and is not recommended for those under 18 years of age. While taking this medication, periodic checks of blood glucose control are required, and interactions with other medications should be discussed with a healthcare professional.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best maintained at room temperature between 1 to 30 degrees Celsius. This will help the medication retain its effectiveness for a longer duration and be safely used.
Light brownish-purple, bilaterally convex oval film-coated tablets
60 tablets/box [10 tablets/PTP x 6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.